Insulin Receptor (1142 - 1153), pTyr1150, Biotinylated

Insulin Receptor (1142 - 1153), pTyr1150, Biotinylated Struktur
CAS-Nr.
Englisch Name:
Insulin Receptor (1142 - 1153), pTyr1150, Biotinylated
Synonyma:
Insulin Receptor (1142 - 1153), pTyr1150, Biotinylated;BIOTIN-THR-ARG-ASP-ILE-TYR-GLU-THR-ASP-PTYR-TYR-ARG-LYS
CBNumber:
CB72476664
Summenformel:
Molgewicht:
0
MOL-Datei:
Mol file

Insulin Receptor (1142 - 1153), pTyr1150, Biotinylated Eigenschaften

Sicherheit

Insulin Receptor (1142 - 1153), pTyr1150, Biotinylated Chemische Eigenschaften,Einsatz,Produktion Methoden

Insulin Receptor (1142 - 1153), pTyr1150, Biotinylated Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Insulin Receptor (1142 - 1153), pTyr1150, Biotinylated Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 13)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
GL Biochem (Shanghai) Ltd 21-61263452 13641803416
ymbetter@glbiochem.com China 9981 64
Nanjing Peptide Biotech Ltd. 025-025-58361106-805-805 13082558573
liugang@njpeptide.com China 9962 55
Chengdu Youngshe Chemical Co., Ltd. +86-17380623303 +86-17380623303
Caroline@youngshechem.com China 5948 58
Hangzhou Peptidego Biotech Co.,Ltd. 0571-87213919
eric@peptidego.com China 6526 58
Nanjing Meihao Pharmaceutical Technology Co., Ltd. meitaochem@126.com
meitaochem@126.com China 19105 58
Hangzhou Go Top Peptide Biotech 0571-88211921 13355716090
Sales@gotopbio.com China 2842 58
Nanjing Shizhou Biology Technology Co.,Ltd 13675144456
alan.chow@synzest.com China 9471 58
Shaoxing Junyu Biotechnology Co., LTD 0571-88211921 15572296305
sales4@gotopbio.com China 5144 58
Hangzhou Sinoda Pharmaceutical Technology Co. LTD 0571-87213919 17306812703
3007955328@qq.com China 6213 58
Hangzhou Baige Pharmaceutical Technology Co. , Ltd. 0571-85350119 15888826472
15888826472@163.com China 2729 58

  • BIOTIN-THR-ARG-ASP-ILE-TYR-GLU-THR-ASP-PTYR-TYR-ARG-LYS
  • Insulin Receptor (1142 - 1153), pTyr1150, Biotinylated
Copyright 2019 © ChemicalBook. All rights reserved